1. Sahu, Roja, Pattanayak, Shakti P. . Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets. In Current gene therapy, 20, 237-258. doi:10.2174/1566523220999200731002408. https://pubmed.ncbi.nlm.nih.gov/32807051/
2. Liu, Chaoqun, Pan, Zhihua, Chen, Qian, Zhou, Rui, Zhao, Liang. 2021. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer. In Journal of experimental & clinical cancer research : CR, 40, 297. doi:10.1186/s13046-021-02059-6. https://pubmed.ncbi.nlm.nih.gov/34551797/
3. Zhang, Qiang, Liu, Sen, Wang, Hongjin, Lin, Tianxin, Chen, Xu. 2023. ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2205613. doi:10.1002/advs.202205613. https://pubmed.ncbi.nlm.nih.gov/36670069/
4. Ono, Hiroaki, Basson, Marc D, Ito, Hiromichi. 2015. PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer. In Molecular cancer research : MCR, 13, 1174-84. doi:10.1158/1541-7786.MCR-15-0034. https://pubmed.ncbi.nlm.nih.gov/26013168/
5. Mathur, Priya S, Gierut, Jessica J, Guzman, Grace, Perekatt, Ansu O, Tyner, Angela L. 2016. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer. In Molecular cancer research : MCR, 14, 563-73. doi:10.1158/1541-7786.MCR-15-0450. https://pubmed.ncbi.nlm.nih.gov/26983689/
智鼠故事 
